AVRX

Avalon (AVRX)

Avalon Pharmaceuticals (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AVRX

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2009/05/14	04 : 39	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/05/07	05 : 48	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/05/07	05 : 46	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/04/29	06 : 05	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/04/29	05 : 49	Business Wire	Avalon Pharmaceuticals Announces Special Meeting Date	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/04/08	04 : 00	Business Wire	Avalon Pharmaceuticals Receives Audit Opinion Containing Going Concern Statement	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/04/02	23 : 24	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/04/02	23 : 22	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/04/01	05 : 02	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/03/18	06 : 07	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/03/18	06 : 05	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/03/18	04 : 00	Business Wire	Avalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq Delisting	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/03/11	05 : 07	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/02/18	07 : 22	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/02/18	01 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/02/14	05 : 10	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/02/14	04 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/02/12	06 : 11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/02/11	07 : 04	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/01/31	06 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/01/22	06 : 19	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/01/15	01 : 56	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2009/01/15	01 : 54	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/12/23	06 : 58	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/12/23	06 : 56	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/12/23	06 : 23	Business Wire	Avalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency Notice	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/11/26	06 : 06	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/11/26	04 : 18	Business Wire	Avalon Pharmaceuticals Receives NASDAQ Deficiency Notice	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/11/14	02 : 04	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)
2008/11/11	03 : 39	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:AVRX	Avalon Pharmaceuticals (MM)